Sarah Gheuens's Net Worth
$820 Thousand
Who is Sarah Gheuens?
Sarah Gheuens does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS, INC., and Viridian Therapeutics, Inc.\DE.
SEC CIK
Sarah Gheuens's CIK is 0001881190
Past Insider Trading and Trends
2023 was Sarah Gheuens's most active year for acquiring shares with 7 total transactions. Sarah Gheuens's most active month to acquire stocks was the month of February. 2022 was Sarah Gheuens's most active year for disposing of shares, totalling 8 transactions. Sarah Gheuens's most active month to dispose stocks was the month of January. 2023 saw Sarah Gheuens paying a total of $0.00 for 132,869 shares, this is the most they've acquired in one year. In 2022 Sarah Gheuens cashed out on 20,385 shares for a total of $138,001.23, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $23.819
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.33% | 5.19K |
$32.57 | -$86,049.94 | 39.07K |
Scheduled
|
Mar 1 - Mar 5
| ||
Form 4
| +4.76% | 1.52K |
$25.14 | -$16,139.88 | 33.43K |
Scheduled
|
Feb 12 - Feb 14
| ||
Form 4
| +14.50% | 4.04K |
$21.64 | -$36,961.12 | 31.91K |
Scheduled
|
Jan 20 - Jan 24
| ||
Form 4
| +13.02% | 3.21K |
$22.99 | -$41,129.11 | 27.87K |
Scheduled
|
Jan 5 - Jan 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +20.10% | 4.04K |
$28.36 | -$48,410.52 | 24.16K |
Jun 28 - Jun 30
| |||
Form 4
| +15.50% | 2.7K |
$25.02 | -$28,372.68 | 20.12K |
Mar 1 - Mar 3
| |||
Form 4
| +9.00% | 1.4K |
$28.44 | -$21,557.52 | 17.01K |
Feb 10 - Feb 14
| |||
Form 4
| +73.14% | 6.59K |
$28.48 | -$79,259.84 | 15.61K |
Dec 23 - Dec 28
| |||
Form 4
| +6.94% | 585 |
$28.83 | -$7,149.84 | 9.01K |
Dec 2 - Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +42.48% | 2.32K |
$29.08 | -$27,771.40 | 7.77K |
Feb 18 - Feb 22
| |||
Form 4
| +34.68% | 1.4K |
$31.43 | -$23,820.15 | 5.45K |
Feb 10
| |||
Form 4
| +16.93% | 586 |
$35.00 | -$8,680.00 | 4.05K |
Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Viridian Therapeutics, Inc.\DE (VRDN) Snapshot price: $18.49
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||